[
    {
        "biomarker_canonical_id": "BD0279",
        "biomarker_id": "BD0279-1",
        "biomarker": "presence of mutation in CR2",
        "assessed_biomarker_entity_id": "P20023-1",
        "assessed_entity_type": "protein",
        "assessed_biomarker_entity": "Complement receptor type 2",
        "specimen": "blood (0000178)",
        "best_biomarker_role": "risk",
        "condition": "systemic lupus erythematosus (DOID:9074)",
        "component_count": 1,
        "component_evidence_count": 1,
        "global_evidence_count": 1,
        "hit_score": 0.3,
        "record_id": "BD0279-1",
        "record_type": "biomarker"
    },
    {
        "biomarker_canonical_id": "BD0281",
        "biomarker_id": "BD0281-1",
        "biomarker": "increased PSA level",
        "assessed_biomarker_entity_id": "P07288-1",
        "assessed_entity_type": "protein",
        "assessed_biomarker_entity": "Prostate-specific antigen",
        "specimen": "blood serum (0001977)",
        "best_biomarker_role": "diagnostic",
        "condition": "prostate cancer (DOID:10283)",
        "component_count": 1,
        "component_evidence_count": 1,
        "global_evidence_count": 1,
        "hit_score": 0.3,
        "record_id": "BD0281-1",
        "record_type": "biomarker"
    },
    {
        "biomarker_canonical_id": "BD0291",
        "biomarker_id": "BD0291-1",
        "biomarker": "increased level of K18-M65",
        "assessed_biomarker_entity_id": "P05783-1",
        "assessed_entity_type": "protein",
        "assessed_biomarker_entity": "Keratin, type I cytoskeletal 18",
        "specimen": "blood serum (0001977)",
        "best_biomarker_role": "diagnostic",
        "condition": "alcohol-associated liver disease (DOID:0070658)",
        "component_count": 1,
        "component_evidence_count": 2,
        "global_evidence_count": 2,
        "hit_score": 0.5,
        "record_id": "BD0291-1",
        "record_type": "biomarker"
    }
]
